Michael Graham, MD, PhD, co-chair of the Society of Nuclear Medicine and Molecular Imaging’s Clinical Trials Network and a professor of radiology and radiation oncology at the University of Iowa Carver College of Medicine in Iowa City, Iowa, took some time to speak with Molecular Imaging Insight in an exclusive interview covering the latest developments in PET radiopharmaceuticals, from drugs just approved and blazing trail in clinical use, to compounds in the far reaches of research. {read more here}